Meet Inspiring Speakers and Experts at our 3000+ Global Conference Series LLC LTD Events with over 1000+ Conferences, 1000+ Symposiums
and 1000+ Workshops on Medical, Pharma, Engineering, Science, Technology and Business.

Explore and learn more about Conference Series LLC LTD : World’s leading Event Organizer


Global Summit on Heart Diseases and Therapeutics

Chicago, USA

Mebratu Alebachew Gebrie

Mebratu Alebachew Gebrie

University of Verona, Italy

Title: The outcome of percutaneous atrial septal defect / patent foramen ovale closure, 15 years single center experience


Biography: Mebratu Alebachew Gebrie


King et al., first time described Percutaneous Trans-catheter Closure in 1976. After that, with time after Paediatric population, catheter interventions for atrial septal defect (ASD) have been adapted for adult population. The most useful clinical benefits of this procedure are the significant improvement of symptoms and routine life activities without major cardiac surgery.This study aimed to assess a single institutional experience of the ASD closure and Patent Foramen Ovale Repair early and late outcome after Percutaneous Transcatheter Closure.A retrospective observational cohort study designed for percutaneous PFO/ASD closure patients at a single centre. We enrolled study group from February 2000 to June 2015. We collected data from patient`s electronic folders. In entire population, N=126 (80%) and N=25 (20%) of the patients underwent PFO and ASD closure, respectively.